Visceral sensitivity index of patients with irritable bowel syndrome after COVID-19 infection
- Authors: Feklina I.Y.1, Mnatsakanyan M.G.1, Pogromov A.P.1, Tashchyаn O.V.1
-
Affiliations:
- Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 24, No 5 (2022)
- Pages: 339-342
- Section: Gastroenterology
- URL: https://journal-vniispk.ru/2075-1753/article/view/109390
- DOI: https://doi.org/10.26442/20751753.2022.5.201797
- ID: 109390
Cite item
Full Text
Abstract
Aim. To perform comparative analysis of visceral sensitivity index (VSI) of patients with previously diagnosed irritable bowel syndrome (IBS) and of patients with IBS symptoms after COVID-19 infection.
Materials and methods. The study was carried out on the basis of University Clinical Hospital №1; 200 patients with COVID-19 infection were examined. Selection criteria were the recommendations of the Rome Consensus IV (2016). Fourteen patients met the criteria for IBS (Rome IV). Forty patients with a verified diagnosis of IBS before the COVID-19 pandemic (Group 2) were selected as a comparison group. The control group included 50 healthy respondents (group 3). Group 1 included 14 patients; Group 2 included 40 patients (54 patients in total): 37 women and 17 men. The control group included 50 patients: 23 men and 27 women. VSI was estimated in the studied groups.
Results. No statistically significant difference of VSI index (p>0.05) was revealed while comparing two studied groups (group 1 and group 2). In group 1 and group 2 the mean values of VSI were 24.57±5.47 and 33.98±2.55 respectively. Absence of significant differences allows to assume from the position of biopsychosocial model that the patients were initially predisposed to IBS development.
Conclusion. A new coronavirus infection is one of the triggers for the development of IBS 6 months after COVID-19 infection.
Full Text
##article.viewOnOriginalSite##About the authors
Iana Yu. Feklina
Sechenov First Moscow State Medical University (Sechenov University)
Author for correspondence.
Email: janafeklina@gmail.com
ORCID iD: 0000-0003-2344-1629
Graduate Student, Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation, MoscowMarina G. Mnatsakanyan
Sechenov First Moscow State Medical University (Sechenov University)
Email: mnatsakanyan08@mail.ru
ORCID iD: 0000-0001-9337-7453
D. Sci. (Med.), Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation, MoscowAlexander P. Pogromov
Sechenov First Moscow State Medical University (Sechenov University)
Email: pogromov.alexander@yandex.ru
ORCID iD: 0000-0002-7426-4055
D. Sci. (Med.), Prof., Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation, MoscowOlga V. Tashchyаn
Sechenov First Moscow State Medical University (Sechenov University)
Email: olgatash1@rambler.ru
ORCID iD: 0000-0001-6759-6820
Cand. Sci. (Med.), Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation, MoscowReferences
- Sperber AD, Dumitrascu D, Fukudo S, et al. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review. Gut. 2017;66(6):1075-82. doi: 10.1136/gutjnl-2015-311240
- Drossman DA, Hasler WL. Rome IV – Functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150(6):1257-61.
- Black CJ, Yiannakou Y, Houghton LA, et al. Anxiety-related factors associated with symptom severity in irritable bowel syndrome. Neurogastroenterol Motil. 2020;32(8):e13872. doi: 10.1111/nmo.13872
- Tanaka Y, Kanazawa M, Fukudo S, Drossman DA. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17(2):131-9. doi: 10.5056/jnm.2011.17.2.131
- Labus JS, Bolus R, Chang L, et al. The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther. 2004;20(1):89-97. doi: 10.1111/j.1365-2036.2004.02007.x
- Labus JS, Mayer EA, Chang L, et al. The Central Role of Gastrointestinal-Specific Anxiety in Irritable Bowel Syndrome: Further Validation of the Visceral Sensitivity Index. Psychosom Med. 2007;69(1):89-98. doi: 10.1097/PSY.0b013e31802e2f24
- Ghoshal UC, Ghoshal U, Rahman MM, et al. Post-infection functional gastrointestinal disorders following coronavirus disease-19: A case-control study. J Gastroenterol Hepatol. 2022;37(3):489-98. doi: 10.1111/jgh.15717
- Settanni CR, Ianiro G, Ponziani FR, et al. COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms. World J Gastroenterol. 2021;27(43):7433-45. doi: 10.3748/wjg.v27.i43.7433
- Drossman DA, Tack J. Rome Foundation Clinical Diagnostic Criteria for Disorders of Gut-Brain Interaction. Gastroenterology. 2022;162(3):675-9. doi: 10.1053/j.gastro.2021.11.019
- Porter CK, Faix DJ, Shiau D, et al. Postinfectious gastrointestinal disorders following norovirus outbreaks. Clin Infect Dis. 2012;55(7):915-22. doi: 10.1093/cid/cis576
- Rusu F, Mocanu L, Dumitraşcu DL. Phenotypic features of patients with post-infectious irritable bowel syndrome. Med Pharm Rep. 2019;92(3):239-45. doi: 10.15386/mpr-1317
- Klem F, Wadhwa A, Prokop LJ, et al. Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis. Gastroenterology. 2017;152(5):1042-54.e1. doi: 10.1053/j.gastro.2016.12.039
Supplementary files
